NEW YORK, Nov. 04, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased National Beverage Corp. (NASDAQ:FIZZ) securities between July 16, 2015 and September 28, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/national-beverage-corp. There is no cost or obligation to you.
According to the complaint, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that it lacked effective internal controls over financial reporting.
On September 27, 2016, a report from Glaucus Research was issued alleging, among other allegations, that: the Company’s former CEO and Chairman admitted to “manipulating FIZZ’s earnings…[and] directing his son to create fake invoices”; the Company refused to allow a potential acquirer to perform adequate due diligence on the Company, thus leading to the failure of the transaction; and that the Company’s officers are “compensated by a privately held company” that disallows shareholder visibility. Following this report, shares fell more than 8% to close at $42.67 per share on September 28, 2016.
If you suffered a loss in National Beverage you have until December 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/national-beverage-corp.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



